ESOI/EuSoMII Annual Meeting 2016
Patient Workflow: from A to Z
Imaging informatics in oncology
October 6-8, 2016

Registration is open now! Please click here for your registration!

You may find more details about the congress here.


ESOI/EORTC Autumn Workshop 2016
Imaging in assessing response to cancer therapy

November 9-11, 2016

Registration is open now! Please click here to register!

You may find more details about the workshop here.



ESOI Webinars 2016

ESOI started in May 2015 to offer a series of educational webinars with various topics related to oncologic imaging and has continued with another series in 2016.
All topics and how/where to register will be announced shortly.
ESOI has planned 11 educational webinars for 2016. Each webinar will last approximately 60 minutes (50 min. presentation and 10 min. for discussion/questions).

Registration for the first 2 online educational webinars will be free of charge and will be open to every interested participant. Webinar 3-11 will be free of charge but only open to active ESOI members. Membership is offered for 20,00 euro to full and associate members and for 10,00 euro to residents.

The online educational webinars of ESOI are kindly supported by Bracco.

Upcoming Webinars 2016


6. Imaging of biliary tract tumours

June 22, 2016 - 18:00 CEST
Riccardo Manfredi, Verona/IT


Cholangiocarcinoma is a malignant tumor arising from the epithelium of the bile ducts. The relative incidence of cholangiocarcinoma among primary liver cancer reported in autopsy series ranges from 5 to 30%; it is, however, the most common primary malignancy of the biliary tree. Most of these tumors are adenocarcinomas. The Liver Cancer Study Group of Japan has proposed a new classification based on growth characteristics, with tumors being identified as mass-forming, periductal-infiltrating, and intraductal- growing types. This classification is considered to be the most reasonable because it describes the gross  appearance,  growing characteristics, biologic behavior, and prognostic implication for patients and because it is helpful for radiologic interpretation

The imaging evaluation of patients with hilar cholangiocarcinoma has traditionally included computed tomography and sonography or a combination of the two techniques for diagnosis and preoperative assessment of resectability. In recent years, MR imaging in conjunction with MR cholangiopancreatography (MRCP), has proved to be helpful in diagnosing hilar cholangiocarcinoma and in determining resectability.

Cholangiocarcinoma appears as a moderately irregular thickening of the bile duct wall (>5 mm), with symmetrical upstream dilation of the intrahepatic bile ducts. Sometimes it may be difficult to differentiate the periductal-infiltrating type of cholangiocarcinoma, encompassing the bile duct confluence and the proximal segment of the common bile duct, from the intraductal-growing type, especially when the lesion is small.

Learning Points:

- To illustrate classification of cholangiocellular carcinoma
- To illustrate diagnostic imaging findings of mass forming cholangiocarcinoma and  of periductal/infiltrating and intraductal-growing types of cholangiocarcinoma
- To become familiar with therapeutic options of cholangiocarcinoma (surgery and palliative treatments) prognostic implication according to the type of cholangiocarcinoma


For your registration please click here:



ESOI Educational Programme 2016

Dear Member,

in 2015 the European Society of Oncologic Imaging (ESOI) membership reached the 300 mark and has more than doubled since 2014. This is a great success considering ESOI is growing in a very competitive environment and in challenging economic climate. What is it in ESOI that attracts radiologists? First, we must acknowledge that in the last decade innovation in medicine has been largely concentrated in the field of Oncology, including the advent of targeted drugs that allow treatment to be tailored to the individual patient; Hippocrate’s prophecy of over 2000 years ago has become true. So called precision medicine requires more and more precision in imaging, in the different stages of disease.

This cultural change has increased radiologists' need for targeted training. ESOI's contribution in 2015 has been the organization of multidisciplinary organ based workshops, including the Workshop on Pelvic Cancer in Maastricht, NL and a Hands-on workshop on Staging and Response to Therapy in Munich, DE. Both workshops were fully booked and very successful. Furthermore in 2015 ESOI introduced a Webinar series. Six one-hour lectures were delivered by a very experienced faculty and reached out to radiologists worldwide. Over 450 registrants from all continents participated into this pilot program, where participants had the opportunity to interact directly with the lecturer during the final discussion time.
Finally the first ever ESOI Scientific Meeting in Turin in 2015 saw the participation of almost 200 imaging doctors. The main objective of the Turin Meeting was to promote oncologic imaging in the multidisciplinary management of cancer patients, and to reach out to non-imaging oncologic societies, to industry and to cancer patient’s organizations, in order to foster a common view and common strategies. This was accomplished with collaborations with the European Society of Medical oncology (ESMO) and the European Organisation for Research and Treatment of Cancer (EORTC). A joint educational program will start in 2016 with the incorporation of a joint ESOI/ESMO imaging session in the ESMO 2016 annual meeting in Copenhagen, and  with the organization of a joint ESOI/ESMO course in oncologic imaging, which will take place in spring 2017. Future workshops in  Imaging Tumor response to Therapy will be in collaboration with the EORTC.

This year we will expand our educational programme further. Two series of Webinars will be offered in order to support the need of the general radiologist and the oncologic imaging specialist. The first series will include 11 Educational Webinars given by an internationally recognized faculty, encompassing broad topics related to cancer imaging. The second series, entitled Tumor Board Webinars will be directed at doctors with a special interest in Oncology. The latter will involve a multidisciplinary team comprising a radiologist and 2 specialists from other disciplines, i.e. surgeon, oncologist, radiotherapist, pathologist, etc. As part of the webinar the “board” will present and discuss clinical cases.

The 2016 ESOI educational programme will also include the following 2 workshops: A case based approach to MRI interpretation & reporting of cancer: Top tips, tricks & pitfalls will be organized in Amsterdam on June 23-24 and the "Imaging Tumor response to Therapy" workshop which will be in Rome in November, and organised jointly with EORTC. ESOI will organize its annual meeting in Valencia on October 7-8, jointly with the European Society of Medical Imaging Informatics (EuSoMII).

Finally, let me sum up for you the most important benefits of being an ESOI member in 2016. First, you will have access to all 2016 Webinars for free and to all the recordings from the 2015 Webinar programme. Secondly, ESOI members will benefit from reduced fees for all other educational activities, i.e. workshops and annual meeting. 

ESOI is looking forward to welcoming you soon to one of the events in 2016. Kindly frequently check the ESOI website for further details.

We would like to thank you very much for your support of the society with your active membership and  wish you a successful 2016!


Prof. Daniele Regge (ESOI President)